Trial Summary
What is the purpose of this trial?
This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health Inequities by Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to mitigate and understand health disparities in risk factor control of chronic conditions, (hypertension, heart failure, and coronary heart disease) which drive downstream lifespan inequality. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control).
Research Team
Steven J Korzeniewski, PhD
Principal Investigator
Wayne State University
Eligibility Criteria
This trial is for individuals with high blood pressure in Detroit, Michigan, and Cleveland, Ohio. Participants are being recruited from those attending Wayne Health Mobile Health Unit events to study factors affecting their blood pressure and health outcomes.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Text Message Reminder (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wayne State University
Lead Sponsor
Amanda Bryant-Friedrich
Wayne State University
Chief Executive Officer since 2023
PhD in Pharmaceutical Sciences
Dr. Polsky
Wayne State University
Chief Medical Officer since 2023
MD from Wayne State University